Aerosolized antibiotics for non-cystic fibrosis bronchiectasis

被引:43
作者
Rubin, Bruce K. [1 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Pediat, Winston Salem, NC 27157 USA
关键词
tobramycin; colistin; bronchiectasis; cystic fibrosis; Pseudomonas aeruginosa; aerosol therapy;
D O I
10.1089/jamp.2007.0652
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
There are strong data supporting using the use of aerosolized antibiotics for the treatment of Gram-negative infections in patients with cystic fibrosis (CF). The regular use of aerosol tobramycin or colistin can decrease exacerbations of lung disease, decrease bacteria counts, and improve pulmonary function in persons with CF and Pseudomonas aeruginosa airway infection. Bronchiectasis is caused by reoccurring or continuous presence of bacteria in association with airway obstruction. Although CF is the most common cause of childhood bronchiectasis, there are many other causes. Because secretions in the bronchiectasis airway are similar to the pus found in the CF airway, and because pulmonary complications and progression of disease in non-CF bronchiectasis is similar to CF bronchiectasis, many centers treat patients with bronchiectasis using aerosolized tobramycin solution for inhalation (TSI). There have been only a few small studies of aerosolized antibiotics to treat pseudomonas infection in subjects with non-CF bronchiec.tasis. Unlike the CF experience, there does not seem to be an improvement of pulmonary function after treatment with aerosol tobramycin in this population despite a decreased sputum bacterial density and a trend toward a decrease in risk of hospitalization. Furthermore, the risk of adverse events such as bronchospasm may be more common in adults with non-CF bronchiectasis than reported in the CF population.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 24 条
[1]   Bronchial constriction and inhaled colistin in cystic fibrosis [J].
Alothman, GA ;
Ho, B ;
Alsaadi, MM ;
Ho, SL ;
O'Drowsky, L ;
Louca, E ;
Coates, AL .
CHEST, 2005, 127 (02) :522-529
[2]   Evaluation of bronchial constriction in children with cystic fibrosis after inhaling two different preparations of tobramycin [J].
Alothman, GA ;
Alsaadi, MM ;
Ho, BL ;
Ho, SL ;
Dupuis, A ;
Corey, M ;
Coates, AL .
CHEST, 2002, 122 (03) :930-934
[3]   Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis [J].
Barker, AF ;
Couch, L ;
Fiel, SB ;
Gotfried, MH ;
Ilowite, J ;
Meyer, KC ;
O'Donnell, A ;
Sahn, SA ;
Smith, LJ ;
Stewart, JO ;
Abuan, T ;
Tully, H ;
Van Dalfsen, J ;
Wells, CD ;
Quan, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) :481-485
[4]   Medical progress - Bronchiectasis [J].
Barker, AF .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (18) :1383-1393
[5]   Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis [J].
Bilton, Diana ;
Henig, Noreen ;
Morrissey, Brian ;
Gotfried, Mark .
CHEST, 2006, 130 (05) :1503-1510
[6]   Regional deposition of coarse particles and ventilation distribution in healthy subjects and patients with cystic fibrosis [J].
Brown, JS ;
Zeman, KL ;
Bennett, WD .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2001, 14 (04) :443-454
[7]   Mucus properties in children with primary ciliary dyskinesia - Comparison with cystic fibrosis [J].
Bush, A ;
Payne, D ;
Pike, S ;
Jenkins, G ;
Henke, MO ;
Rubin, BK .
CHEST, 2006, 129 (01) :118-123
[8]   Treatment with tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa [J].
Couch, LA .
CHEST, 2001, 120 (03) :114S-117S
[9]   CONTAMINATED MEDICATION NEBULIZERS IN MECHANICAL VENTILATOR CIRCUITS - SOURCE OF BACTERIAL AEROSOLS [J].
CRAVEN, DE ;
LICHTENBERG, DA ;
GOULARTE, TA ;
MAKE, BJ ;
MCCABE, WR .
AMERICAN JOURNAL OF MEDICINE, 1984, 77 (05) :834-838
[10]   Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: Effect on lung function, health status and sputum [J].
Daviskas, E ;
Anderson, SD ;
Gomes, K ;
Briffa, P ;
Cochrane, B ;
Chan, HK ;
Young, IH ;
Rubin, BK .
RESPIROLOGY, 2005, 10 (01) :46-56